42% of vaccinated women reported heavier menstrual bleeding following vaccine

TCS Wire

August 10, 2022

A study published in July found that 42.1% of women who got a COVID vaccine reported heavier than usual menstrual bleeding following the jab.

42.1% of vaccinated women reported heavier menstrual bleeding post-vaccine
42.1% of vaccinated women reported heavier menstrual bleeding post-vaccine

According to researchers, both women who menstruate and women who do not usually menstruate reported heavier than usual periods or “breakthrough bleeding” following inoculation with COVID vaccines.

Out of a sample size of 39,129 fully vaccinated women, 42.1% reported heavier menstrual flow after vaccination, 14.3% reported not having a heavier menstrual flow, and 43.6% reported no change.
The study further found that 71% of women on long-acting contraceptives, 39% of people taking artificial hormones, and 66% of postmenopausal women reported breakthrough bleeding.

“We found that increased/breakthrough bleeding was significantly associated with age, systemic vaccine side effects (fever and/or fatigue), history of pregnancy or birth, and ethnicity. Generally, changes to menstrual bleeding are not uncommon or dangerous, yet attention to these experiences is necessary to build trust in medicine,” researchers write.

Women reported noticing changes in their period one to seven days after taking a vaccine, with 31.4% reporting changes within a week after their first dose and 37% seeing changes after their second. 25.9% of women reported changes in week two after their first jab, while 23.6% reported changes after their second jab in the second week. 29.9% reported changes to their menstruation even after two weeks after their first jab, while 26.8% of the double vaccinated reported the same.

Researchers found that 54.3% of respondents reported common systemic vaccine side effects (headache, nausea, fever, or fatigue) after the first jab, while 74.6% experienced common systemic vaccine side effects after the second. In addition, 40.6% experienced systemic side effects after both doses.

Over one-third of respondents who regularly take “gender-affirming hormone treatments” experienced breakthrough bleeding after taking the vaccine. “The majority of premenopausal respondents on long-acting reversible contraceptives (LARC) and the majority of postmenopausal respondents experienced breakthrough bleeding as well,” researchers write.

“Among regularly menstruating respondents, those who had heavier bleeding after vaccine were more likely to be older, be Hispanic/Latinx, have experienced fever and/or fatigue side effects, have a lighter typical menstrual flow, have been pregnant, and/or have given birth.”

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

Quebec became the first province to stop advising young and healthy Canadians to get a COVID booster. 

Mike Campbell

February 3, 2023

Trending News

Project Veritas released extended footage of a Pfizer employee expressing concern that his company’s vaccine is causing adverse effects. 

Mike Campbell

February 3, 2023

Trending News

Data shows Canada had way more Covid deaths in 2022, with a 85% vaccinated population than in 2020, with a 0% vaccinated population.

Mike Campbell

January 30, 2023

Trending News

A Pfizer employee who was secretly recorded saying his company has considered mutating the Covid virus for profit said he was lying to impress a date. 

Mike Campbell

January 27, 2023

Trending News

Over 53,000 Canadians have suffered an adverse effect from the Covid-19 vaccine, whereas just under 50,000 Canadians have died from the virus. 

Mike Campbell

January 17, 2023

Trending News

Alberta professor and Covid-19 vaccine influencer Tim Caulfield blocked a debate moderator on Twitter after she shared an open letter from vaccine critic Byram Bridle challenging Caulfield to a debate.

Mike Campbell

January 16, 2023

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.